Aptose Biosciences Inc Sustainability Reports
A clinical-stage biotechnology company that develops targeted, small-molecule agents for precision treatment of hematologic malignancies, such as acute myeloid leukemia (AML).
Sector: Manufacturing
Country: Canada
Exchange: Toronto Stock Exchange
LEI: 5299003EUHV3CD08L949
7 reports from 2019 to 2025
